Mycophenolate versus Placebo for Systemic Sclerosis-Related Interstitial Lung Disease: An Analysis of Scleroderma Lung Studies I and II

OBJECTIVE: To compare mycophenolate (MMF) with placebo for the treatment of systemic sclerosis-related interstitial lung disease (SSc-ILD). METHODS: Participants enrolled in the placebo arm of Scleroderma Lung Study (SLS) I and the MMF arm of SLS II were included. SLS I randomized participants to or...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Arthritis Rheumatol
Главные авторы: Volkmann, Elizabeth R., Tashkin, Donald P., Li, Ning, Roth, Michael D., Khanna, Dinesh, Hoffmann-Vold, Anna-Maria, Kim, Grace, Goldin, Jonathan, Clements, Philip J., Furst, Daniel E., Elashoff, Robert M.
Формат: Artigo
Язык:Inglês
Опубликовано: 2017
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5560126/
https://ncbi.nlm.nih.gov/pubmed/28376288
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/art.40114
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы